Literature DB >> 2957537

Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.

F Koba, T Akiyoshi, S Arinaga, T Wada, H Tsuji.   

Abstract

The cell-mediated cytotoxic activities of cells from the perigastric lymph nodes (LNC) were assayed in patients with gastric carcinoma. These activities were compared with those of the peripheral blood mononuclear cells (PBM), and also with the LNC of patients with benign lesions. The capacity of LNC to be converted to cytotoxic cells in mixed cell culture was significantly impaired in the cancer patients as compared to that of either the PBM from the same patient, or the LNC from patients with benign lesions. The natural killer cell (NK) activity of LNC was significantly lower than that of the PBM in both groups of patients. The cytotoxic activity induced by phytohemagglutinin activation (PAK) in the LNC from patients with carcinoma, as well as from those with benign lesions was also significantly decreased, when compared to that of the PBM, although the ability of LNC to produce interleukin 2 (IL 2) was significantly increased. The ability of these cells to generate cytotoxicity after activation with IL 2 (LAK) was therefore examined, and a decreased capacity in LNC was observed. These results indicated that the ability of T cells in LNC to develop into cytotoxic cells in patients with gastric carcinoma was impaired, and that the nonspecific cytotoxicity, including NK or PAK, as well as LAK activity, was essentially low in the perigastric lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957537     DOI: 10.1007/bf02470646

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  22 in total

1.  Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation.

Authors:  P Antonelli; W Stewart; B Dupont
Journal:  Clin Immunol Immunopathol       Date:  1981-05

2.  T-lymphocyte subsets in human lymph nodes: relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation.

Authors:  L P Ruco; A Stoppacciaro; M Valtieri; S Uccini; D Vitolo; C D Baroni
Journal:  Clin Immunol Immunopathol       Date:  1984-03

3.  Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

4.  Immunology of tumor infiltrating lymphocytes.

Authors:  E C Holmes
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

5.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.

Authors:  A Mazumder; E A Grimm; H Z Zhang; S A Rosenberg
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

6.  Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.

Authors:  C A Spina; F Dorey; C Vescera; S Brosman; J L Fahey
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection.

Authors:  M Niitsuma; S H Golub; R Edelstein; E C Holmes
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

8.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

Authors:  E A Grimm; R J Robb; J A Roth; L M Neckers; L B Lachman; D J Wilson; S A Rosenberg
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  2 in total

1.  Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.

Authors:  H Matsunaga; Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1988-10

2.  Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.

Authors:  K Kusugami; T Matsuura; T Kawase; K Ina; H Matsunaga; Y Kuwahara; T Inagaki; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1990-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.